Proteomics facility
State of the art proteomic analysis for researchers and industry.
The facility provides a service to multiple research groups across the University of Bristol, but also to many groups from major UK Universities and to industrial partners. The Facility’s user base encompasses a diverse range of research areas, including cell biology, neuroscience, cardiovascular science, infection and immunity, cancer research, evolutionary biology, oral health, small animal medicine and plant and agricultural sciences.
Our dedicated and highly experienced staff can provide advice on all stages of proteomics projects from experimental design and sample preparation through to data analysis.
- ServicesThe facility provides a full range of bespoke proteomics services allowing the isolation, identification and quantitation of proteins of interest for researchers within the University of Bristol and to external academic and industrial clients.
- ResearchAs well as providing a complete sample analysis service, the facility also provides expert advice in experimental design and grant submissions to secure funding for new research initiatives. We aim to provide the best possible service to meet your specific research project's requirements.
- EquipmentAs well as providing a complete sample analysis service, the facility also features excellent and state of the art equipment. We aim to provide the best possible service to meet your specific research project's requirements.
The Facility was created in its present form in 2004 upon the recruitment of Dr Kate Heesom from the Proteomics Methods Development Team at Oxford Glycosciences (UK) Ltd.
Building on gel-based proteomics equipment purchased through a Wellcome Trust - JIF award in 1999, in 2011 the facility acquired an LTQ-Orbitrap Velos mass spectrometer with funding from the Wolfson foundation and the University of Bristol, allowing the development of LCMS-based proteomic applications.
In 2015 capability within the Facility was further enhanced by the purchase of an Orbitrap Fusion Tribrid mass spectrometer with ETD, funded by the Wellcome Trust and the University of Bristol.